EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Tecan Group AG's enterprise value is CHF4,125 Mil.
Tecan Group AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF206 Mil. Therefore, Tecan Group AG's EV-to-EBITDA for today is 20.03.
The historical rank and industry rank for Tecan Group AG's EV-to-EBITDA or its related term are showing as below:
XSWX:TECN'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.18 Med: 21.59 Max: 45.18
Current: 20.03
During the past 13 years, the highest EV-to-EBITDA of Tecan Group AG was 45.18. The lowest was 12.18. And the median was 21.59.
XSWX:TECN's EV-to-EBITDA is ranked worse than 60.54% of 484
companies
in the Medical Devices & Instruments industry
Industry Median: 16.27
vs XSWX:TECN: 20.03
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Tecan Group AG EV-to-EBITDA Historical Data
The historical data trend for Tecan Group AG's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Tecan Group AG's EV-to-EBITDA
For the Medical Instruments & Supplies subindustry, Tecan Group AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tecan Group AG's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tecan Group AG's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Tecan Group AG's EV-to-EBITDA falls into.
Tecan Group AG EV-to-EBITDA Calculation
Tecan Group AG's EV-to-EBITDA for today is calculated as:
Tecan Group AG's current Enterprise Value is CHF4,125 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tecan Group AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF206 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tecan Group AG (XSWX:TECN) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Tecan Group AG's PE Ratio for today is calculated as:
Tecan Group AG's share price for today is CHF326.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tecan Group AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF10.300.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Tecan Group AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life science research markets. The firm operates in two segments; Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, and Partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their own names. A majority proportion of Tecan's revenue is generated in the Americas and Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:TECN has been successfully added to your 